Scleroderma renal crisis with coexisting segmental arterial mediolysis presenting as intraperitoneal bleeding: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
20 Mar 2019
Historique:
received: 30 09 2018
accepted: 23 01 2019
entrez: 21 3 2019
pubmed: 21 3 2019
medline: 23 7 2019
Statut: epublish

Résumé

Segmental arterial mediolysis is a rare nonarteriosclerotic and noninflammatory vascular disease that may cause intraperitoneal bleeding. Scleroderma renal crisis is a rare complication of systemic sclerosis, leading to severe hypertension and renal dysfunction. To the best of our knowledge, this is the first reported case of a patient with concurrent systemic sclerosis with scleroderma renal crisis and pathologically confirmed segmental arterial mediolysis. We report a case of a 68-year-old Chinese woman diagnosed with systemic sclerosis who was found to have coexisting segmental arterial mediolysis. She presented with back pain, and massive intraperitoneal bleeding was detected by computed tomography. She underwent laparotomy, and the bleeding was found to originate from the gastroepiploic artery. The pathological examination demonstrated gastroepiploic arterial dissection caused by segmental arterial mediolysis. After surgery, she developed severe hypertension with hyperreninemia and progressive renal dysfunction. Given the risk factors of corticosteroid administration and the presence of anti-ribonucleic acid polymerase III antibody, she was diagnosed with scleroderma renal crisis. The patient was proved to have a very rare case of coexisting scleroderma renal crisis and segmental arterial mediolysis. There is no known etiological connection between segmental arterial mediolysis and systemic sclerosis or scleroderma renal crisis, but it is possible that coexisting segmental arterial mediolysis and scleroderma renal crisis may have interacted to trigger the development of the other in our patient.

Sections du résumé

BACKGROUND BACKGROUND
Segmental arterial mediolysis is a rare nonarteriosclerotic and noninflammatory vascular disease that may cause intraperitoneal bleeding. Scleroderma renal crisis is a rare complication of systemic sclerosis, leading to severe hypertension and renal dysfunction. To the best of our knowledge, this is the first reported case of a patient with concurrent systemic sclerosis with scleroderma renal crisis and pathologically confirmed segmental arterial mediolysis.
CASE PRESENTATION METHODS
We report a case of a 68-year-old Chinese woman diagnosed with systemic sclerosis who was found to have coexisting segmental arterial mediolysis. She presented with back pain, and massive intraperitoneal bleeding was detected by computed tomography. She underwent laparotomy, and the bleeding was found to originate from the gastroepiploic artery. The pathological examination demonstrated gastroepiploic arterial dissection caused by segmental arterial mediolysis. After surgery, she developed severe hypertension with hyperreninemia and progressive renal dysfunction. Given the risk factors of corticosteroid administration and the presence of anti-ribonucleic acid polymerase III antibody, she was diagnosed with scleroderma renal crisis. The patient was proved to have a very rare case of coexisting scleroderma renal crisis and segmental arterial mediolysis.
CONCLUSIONS CONCLUSIONS
There is no known etiological connection between segmental arterial mediolysis and systemic sclerosis or scleroderma renal crisis, but it is possible that coexisting segmental arterial mediolysis and scleroderma renal crisis may have interacted to trigger the development of the other in our patient.

Identifiants

pubmed: 30890184
doi: 10.1186/s13256-019-1993-z
pii: 10.1186/s13256-019-1993-z
pmc: PMC6425683
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

74

Références

J Vasc Interv Radiol. 2000 Jul-Aug;11(7):865-8
pubmed: 10928523
Rheum Dis Clin North Am. 2003 May;29(2):315-33
pubmed: 12841297
Clin Exp Rheumatol. 2003;21(3 Suppl 29):S29-31
pubmed: 12889219
Lancet. 2006 May 20;367(9523):1683-91
pubmed: 16714190
QJM. 2007 Aug;100(8):485-94
pubmed: 17601770
Pathol Res Pract. 2007;203(11):771-8
pubmed: 17920781
Clin Rev Allergy Immunol. 2011 Apr;40(2):84-91
pubmed: 20012923
Arthritis Care Res (Hoboken). 2010 Nov;62(11):1655-60
pubmed: 20662047
Curr Rheumatol Rep. 2011 Feb;13(1):37-43
pubmed: 21061100
Rev Bras Cir Cardiovasc. 2011 Jan-Mar;26(1):107-15
pubmed: 21881719
Ann Intern Med. 1990 Sep 1;113(5):352-7
pubmed: 2382917
Semin Arthritis Rheum. 2014 Apr;43(5):666-72
pubmed: 24176729
Cardiovasc Intervent Radiol. 2014 Jun;37(3):604-12
pubmed: 24554198
J Rheumatol. 2014 Jun;41(6):1040-8
pubmed: 24833760
Semin Arthritis Rheum. 2015 Jun;44(6):687-94
pubmed: 25613774
Am J Surg Pathol. 1989 Jul;13(7):558-68
pubmed: 2660608
Vasc Med. 2017 Jun;22(3):248-252
pubmed: 28367730
Clin Neuroradiol. 2018 Sep;28(3):445-450
pubmed: 29101412
Medicine (Baltimore). 1974 Jan;53(1):1-46
pubmed: 4808710
Am J Med. 1984 May;76(5):779-86
pubmed: 6372452
Mod Pathol. 1995 Apr;8(3):287-94
pubmed: 7617656
Br J Radiol. 1997 Jun;70(834):656-8
pubmed: 9227264
Lab Invest. 1976 Jul;35(1):23-9
pubmed: 940319
Arthritis Rheum. 1998 Sep;41(9):1613-9
pubmed: 9751093

Auteurs

Shohei Kaneko (S)

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.
Department of Nephrology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Eri Watanabe (E)

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan. eriw@jichi.ac.jp.

Mai Abe (M)

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Shinji Watanabe (S)

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Hiroki Yabe (H)

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Shigehiro Kojima (S)

Department of Surgery, Sainokuni Higashiomiya Medical Center, 1522 Toro-cho, Kita-ku, Saitama, 331-8577, Japan.

Kenji Takagi (K)

Department of Rheumatology, Sainokuni Higashiomiya Medical Center, 1522 Toro-cho, Kita-ku, Saitama, 331-8577, Japan.

Keiji Hirai (K)

Department of Nephrology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Yoshiyuki Morishita (Y)

Department of Nephrology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Chihiro Terai (C)

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH